Justin A. Renz
2014
In 2014, Justin A. Renz earned a total compensation of $7.9M as Executive Vice President, Chief Financial Officer & Treasurer at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $36,000 |
|---|---|
| Option Awards | $7,702,898 |
| Salary | $129,375 |
| Other | $157 |
| Total | $7,868,430 |
Renz received $7.7M in option awards, accounting for 98% of the total pay in 2014.
Renz also received $36K in non-equity incentive plan, $129.4K in salary and $157 in other compensation.
Rankings
In 2014, Justin A. Renz's compensation ranked 794th out of 13,032 executives tracked by ExecPay. In other words, Renz earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 794 out of 13,032 | 94th |
Division Manufacturing | 288 out of 4,966 | 94th |
Major group Chemicals And Allied Products | 96 out of 1,686 | 94th |
Industry group Drugs | 75 out of 1,365 | 95th |
Industry Pharmaceutical Preparations | 69 out of 1,043 | 93rd |
Source: SEC filing on April 29, 2016.
Renz's colleagues
We found four more compensation records of executives who worked with Justin A. Renz at Karyopharm Therapeutics in 2014.
2014
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Worldwide Development Operations
2014
Christopher Primiano
Karyopharm Therapeutics
General Counsel
2014
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2014
Sharon Shacham
Karyopharm Therapeutics